Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)
Turkey · Delayed Price · Currency is TRY 9.17
+0.07 (0.77%)
Last updated: Aug 17, 2026, 12:41 PM GMT+3
IST:ANGEN Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 747.38 | 739.63 | 693.51 | 343.92 | 468.38 | 410.11 | |
Revenue Growth | -3.47% | 6.65% | 101.65% | -26.57% | 14.21% | -2.72% |
Cost of Revenue | 305.76 | 269.63 | 255.58 | 69.4 | 66.77 | 51.43 |
Gross Profit | 441.63 | 470 | 437.92 | 274.51 | 401.61 | 358.68 |
Selling, General & Admin | 480.22 | 463.23 | 398.23 | 268.7 | 146.33 | 41.65 |
Research & Development | - | - | 4.11 | 12.99 | 5.88 | 0.97 |
Other Operating Expenses | 65.35 | 59.79 | 12.85 | 15.71 | -24.8 | 7.51 |
Operating Expenses | 545.57 | 523.02 | 415.19 | 297.4 | 127.42 | 50.13 |
Operating Income | -103.94 | -53.02 | 22.73 | -22.88 | 274.19 | 308.56 |
Interest Expense | -2.63 | -2.4 | -1.94 | -4.87 | -3.49 | -53.17 |
Interest & Investment Income | 7.4 | 14.86 | 22.25 | 67.94 | 102.75 | 10.17 |
Currency Exchange Gain (Loss) | -26.64 | 11.99 | 89.73 | 272.27 | 294.25 | 196.7 |
Other Non Operating Income (Expenses) | -90.58 | -242.92 | -348.98 | -468.45 | -593.41 | - |
EBT Excluding Unusual Items | -216.4 | -271.48 | -216.2 | -155.99 | 74.29 | 462.26 |
Gain (Loss) on Sale of Investments | -0.88 | -0.88 | -4.66 | -13.86 | - | - |
Other Unusual Items | - | - | - | -41.11 | -28.47 | - |
Pretax Income | -217.28 | -272.36 | -220.86 | -210.95 | 45.82 | 462.26 |
Income Tax Expense | 41.15 | 40.37 | 65.63 | -13.63 | 55.88 | 18.88 |
Earnings From Continuing Operations | -258.43 | -312.73 | -286.49 | -197.32 | -10.06 | 443.37 |
Minority Interest in Earnings | - | - | - | - | -11.01 | -10.04 |
Net Income | -258.43 | -312.73 | -286.49 | -197.32 | -21.06 | 433.33 |
Net Income to Common | -258.43 | -312.73 | -286.49 | -197.32 | -21.06 | 433.33 |
Net Income Growth | - | - | - | - | - | 47.70% |
Shares Outstanding (Basic) | 220 | 220 | 220 | 220 | 220 | 151 |
Shares Outstanding (Diluted) | 220 | 220 | 220 | 220 | 220 | 151 |
Shares Change | - | - | - | - | 45.28% | - |
EPS (Basic) | -1.17 | -1.42 | -1.30 | -0.90 | -0.10 | 2.86 |
EPS (Diluted) | -1.17 | -1.42 | -1.30 | -0.90 | -0.10 | 2.86 |
EPS Growth | - | - | - | - | - | 47.70% |
Free Cash Flow | -74.57 | -186.11 | -137.54 | 347.43 | 496.48 | 329.77 |
Free Cash Flow Per Share | -0.34 | -0.85 | -0.63 | 1.58 | 2.26 | 2.18 |
Dividend Per Share | - | - | - | - | 0.596 | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 59.09% | 63.55% | 63.15% | 79.82% | 85.74% | 87.46% |
Operating Margin | -13.91% | -7.17% | 3.28% | -6.65% | 58.54% | 75.24% |
Profit Margin | -34.58% | -42.28% | -41.31% | -57.38% | -4.50% | 105.66% |
Free Cash Flow Margin | -9.98% | -25.16% | -19.83% | 101.02% | 106.00% | 80.41% |
EBITDA | 16.11 | 78.11 | 148.7 | 53.1 | 331.36 | 318.29 |
EBITDA Margin | 2.16% | 10.56% | 21.44% | 15.44% | 70.75% | 77.61% |
D&A For EBITDA | 120.06 | 131.12 | 125.97 | 75.99 | 57.17 | 9.73 |
EBIT | -103.94 | -53.02 | 22.73 | -22.88 | 274.19 | 308.56 |
EBIT Margin | -13.91% | -7.17% | 3.28% | -6.65% | 58.54% | 75.24% |
Effective Tax Rate | - | - | - | - | 121.94% | 4.08% |